320 related articles for article (PubMed ID: 31810439)
1. Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry.
Wang Y; Ma CS; Du X; He L; Li J; Wang GH; Wen D; Dong JZ; Pan JH; Lip GYH
BMC Cardiovasc Disord; 2019 Nov; 19(1):283. PubMed ID: 31810439
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
3. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
[TBL] [Abstract][Full Text] [Related]
4. ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry.
Wang Y; Jiang C; He L; Du X; Guo X; Tang R; Sang C; Long D; Dong J; Hijazi Z; Lip GYH; Ma C
Chin Med J (Engl); 2023 Oct; 136(20):2451-2458. PubMed ID: 37858319
[TBL] [Abstract][Full Text] [Related]
5. Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study.
Admassie E; Chalmers L; Bereznicki LR
J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):329-336. PubMed ID: 29642709
[TBL] [Abstract][Full Text] [Related]
6. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
[No Abstract] [Full Text] [Related]
7. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: a national wide database analysis.
Yang YM; Shao XH; Zhu J; Zhang H; Liu Y; Gao X; Liu LS; Yu LT; Zhao L; Yu PF; Zhang H; He Q; Gu XD
Int J Cardiol; 2014 May; 173(2):242-7. PubMed ID: 24630382
[TBL] [Abstract][Full Text] [Related]
9. The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events.
Atar D; Berge E; Le Heuzey JY; Virdone S; Camm AJ; Steffel J; Gibbs H; Goldhaber SZ; Goto S; Kayani G; Misselwitz F; Stepinska J; Turpie AGG; Bassand JP; Kakkar AK;
Europace; 2020 Feb; 22(2):195-204. PubMed ID: 31747004
[TBL] [Abstract][Full Text] [Related]
10. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.
Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
[TBL] [Abstract][Full Text] [Related]
11. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Taillandier S; Olesen JB; Lane DA; Lallemand B; Lip GY; Fauchier L
Int J Cardiol; 2013 Sep; 167(6):2682-7. PubMed ID: 22795403
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors Associated With Ischemic Stroke in Japanese Patients With Nonvalvular Atrial Fibrillation.
Okumura K; Tomita H; Nakai M; Kodani E; Akao M; Suzuki S; Hayashi K; Sawano M; Goya M; Yamashita T; Fukuda K; Ogawa H; Tsuda T; Isobe M; Toyoda K; Miyamoto Y; Miyata H; Okamura T; Sasahara Y;
JAMA Netw Open; 2020 Apr; 3(4):e202881. PubMed ID: 32293685
[TBL] [Abstract][Full Text] [Related]
13. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of heart rate during atrial fibrillation on clinical outcomes in elderly non-valvular atrial fibrillation patients: ANAFIE Registry sub-cohort study.
Ikeda T; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
J Cardiol; 2023 May; 81(5):441-449. PubMed ID: 36427691
[TBL] [Abstract][Full Text] [Related]
15. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
Link MS; Giugliano RP; Ruff CT; Scirica BM; Huikuri H; Oto A; Crompton AE; Murphy SA; Lanz H; Mercuri MF; Antman EM; Braunwald E;
Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):. PubMed ID: 28077507
[TBL] [Abstract][Full Text] [Related]
16. Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom.
Senoo K; An Y; Ogawa H; Lane DA; Wolff A; Shantsila E; Akao M; Lip GY
Heart; 2016 Dec; 102(23):1878-1882. PubMed ID: 27312001
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk.
Tomlin AM; Lloyd HS; Tilyard MW
Eur J Prev Cardiol; 2017 Feb; 24(3):311-319. PubMed ID: 27798365
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Persistence of Newly Initiated Warfarin Therapy in Chinese Patients With Nonvalvular Atrial Fibrillation.
Wang ZZ; Du X; Wang W; Tang RB; Luo JG; Li C; Chang SS; Liu XH; Sang CH; Yu RH; Long DY; Wu JH; Bai R; Liu N; Ruan YF; Dong JZ; Ma CS
Circ Cardiovasc Qual Outcomes; 2016 Jul; 9(4):380-7. PubMed ID: 27382087
[TBL] [Abstract][Full Text] [Related]
19. Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis.
Chan YH; Lee HF; Chao TF; Wu CT; Chang SH; Yeh YH; See LC; Kuo CT; Chu PH; Wang CL; Lip GYH
Cardiovasc Drugs Ther; 2019 Dec; 33(6):701-710. PubMed ID: 31745687
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolic events in paroxysmal vs. permanent non-valvular atrial fibrillation. Subanalysis of the J-RHYTHM Registry.
Inoue H; Atarashi H; Okumura K; Yamashita T; Kumagai N; Origasa H
Circ J; 2014; 78(10):2388-93. PubMed ID: 25099606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
